The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A meta-analysis of the association between adherence to drug therapy and mortality
Open accessAbstract
OBJECTIVE: To evaluate the relation between adherence to drug therapy, including placebo, and mortality. DESIGN: Meta-analysis of observational studies. DATA SOURCES: Electronic databases, contact with investigators, and textbooks and reviews on adherence. Review methods Predefined criteria were used to select studies reporting mortality among participants with good and poor adherence to drug therapy. Data were extracted for disease, drug therapy groups, methods for measurement of adherence rate, definition for good adherence, and mortality. RESULTS: Data were available from 21 studies (46,847 participants), including eight studies with placebo arms (19,633 participants). Compared with poor adherence, good adherence was associated with lower mortality (odds ratio 0.56, 95% confidence interval 0.50 to 0.63). Good adherence to placebo was associated with lower mortality (0.56, 0.43 to 0.74), as was good adherence to beneficial drug therapy (0.55, 0.49 to 0.62). Good adherence to harmful drug therapy was associated with increased mortality (2.90, 1.04 to 8.11). CONCLUSION: Good adherence to drug therapy is associated with positive health outcomes. Moreover, the observed association between good adherence to placebo and mortality supports the existence of the "healthy adherer" effect, whereby adherence to drug therapy may be a surrogate marker for overall healthy behaviour.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, as adherence with placebo also improves survival, 524 physicians should be aware that adherence to medication may reflect generally better health behaviour.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [524]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Kirk, J. M. W., MacDonald, A., Lavender, P., Dean, J. M., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,902
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Research works printed but not linked: 1
- Tobias A. Assessing the influences of a single study in meta-analysis. Stata Tech Bull 1999;47:15-7.
Cited by
Sorted by citations
Items 701–800 of 1,000
Tran, D. N., Kangogo, K., Amisi, J. A., Kamadi, J., Karwa, R., Kiragu, B., Laktabai, J., Manji, I., Njuguna, B., Szkwarko, D., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273655 · Cited by 11
Alessandria, M., Malatesta, G., Palmo, G. D., Cosentino, M., & Donzelli, A. (2024) · F1000Research · doi:10.12688/f1000research.154058.1 · Cited by 11
Al-Haddad, M., Abdallah, Q., Alshakhsheer, S. M., Alosaimi, S. B., Althmali, A. R., & Alahmari, S. A. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.5965 · Cited by 11
Primary nonadherence (failure to obtain prescribed medicines) among dermatology patients
Richmond, N. A., Lamel, S. A., Braun, L. R., Vivas, A. C., Cucalon, J., Block, S. G., & Kirsner, R. S. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.053 · Cited by 11
Park, J.-H., Lee, Y., Ko, S.-K., & Soo, B. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015010 · Cited by 11
“have improved medication adherence and subsequently treatment outcomes [8,9].”
BackgroundAdachi, R., Josse, R. G., & Russell, R. G. G. (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s17513 · Cited by 11
Impact of bisphosphonates and comorbidities on initial hip fracture prognosis
Fu, T., Huang, T., Sun, C., Shyu, Y., & Chen, F. (2021) · Bone · doi:10.1016/j.bone.2021.116239 · Cited by 12
Chang, D., Chen, W., & Wang, R. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07575-5 · Cited by 13
“Effective physician-patient communication is a basic part of the treatment process [5], which relieves the patient’s psychological burden and leads to better healthcare outcomes [11, 28, 32, 40].”
BackgroundPrimary medication nonadherence in a large primary care population
Singer, A. G., LaBine, L., Katz, A., Yogendran, M. S., & Lix, L. M. (2022) · Canadian Family Physician · doi:10.46747/cfp.6807520 · Cited by 11
Gunnell, A. S., Einarsdóttir, K., Galvao, D. A., Joyce, S., Tomlin, S., Graham, V., McIntyre, C., Newton, R. U., & Briffa, T. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077833 · Cited by 11
“Also, adherence to medication is likely to be associated to a degree with healthy lifestyle factors overall [37].”
BackgroundHochhalter, A. K., Basu, R., Prasla, K., & Jo, C. (2014) · PubMed · Cited by 11
For the Investigators, Sohn, I. S., Kim, C., Oh, B., Hong, T.-J., Park, C. G., Kim, B., & Chung, W. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0156-x · Cited by 11
“A single-pill combination therapy could simplify the antihypertensive regimen, particularly in patients with various comorbidities, which may improve compliance, persistence, and BP control compared with its corresponding free-drug combinations [2, 4, 5].”
BackgroundKovačević, S. V., Miljković, B., Vučićević, K. M., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., & de Gier, J. J. (2017) · Patient Education and Counseling · doi:10.1016/j.pec.2017.05.001 · Cited by 11
Obtaining Valid Estimates of the Effect of CPAP Therapy
Kapur, V. K., & Psaty, B. M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.03.027 · Cited by 11
How to Use Research to Become More Effective Therapists
Wampold, B. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50675-3_14 · Cited by 10
Kalirai, S., Ivanova, J. I., Perez‐Nieves, M., Stephenson, J. J., Hadjiyianni, I., Grabner, M., Pollom, R. D., Geremakis, C. M., Reed, B. L., & Fisher, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s237948 · Cited by 9
Kably, B., Billaud, E. M., Boutouyrie, P., & Azizi, M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01105-6 · Cited by 10
Sabil, A., Blanchard, M., Annweiler, C., Bailly, S., Goupil, F., Pigeanne, T., Trzépizur, W., Gervès‐Pinquié, C., Gagnadoux, F., & the Pays de la Loire Sleep Cohort study group (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17933 · Cited by 10
Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
Kamusheva, M., Vandeva, S., Mitov, K., Parvanova, A., Pesheva, M., Ganov, N., Rusenova, Y., Marinov, L., Getova-Kolarova, V., Elenkova, A. P., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020438 · Cited by 11
Matambisso, G., Brokhattingen, N., Maculuve, S. A., Cisteró, P., Mbeve, H., Escoda, A., Bambo, G., Cuna, B., Melembe, C., Ndimande, N., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106144 · Cited by 12
Non-observance dans le diabète de type 2
Reach, G. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.02.314 · Cited by 10
Chakraborty, S. (2012) · Journal of Risk Research · doi:10.1080/13669877.2012.727098 · Cited by 10
Atlantis, E. E., Grayson, D., Browning, C. J., Sims, J., & Kendig, H. L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2532 · Cited by 10
“The treatment and management of depression with antidepressants in older patients is therefore concerning given the abovementioned lack of evidence for prevention, the already high burden of chronic diseases and prescription medications in this population (Dunstan et al., 2001; Chapman et al., 2005; Simpson et al., 20…”
BackgroundA Comparison of the Effectiveness of a Telephone Coaching Program and a Mail-Based Program
Terry, P. E., Seaverson, E. L. D., Staufacker, M. J., & Gingerich, S. B. (2010) · Health Education & Behavior · doi:10.1177/1090198110367876 · Cited by 12
“A recent meta-analysis of observational studies demonstrated an association between therapy adherence and mortality, theoretically a manifestation of the healthy user effect (Simpson et al., 2006).”
MethodStatin Adherence and Risk of Accidents: A Cautionary Tale
Gersh, B. J. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79764-9 · Cited by 10
Qin, X. S., Teng, T. K., Hung, J., Briffa, T. G., & Sanfilippo, F. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-014397 · Cited by 10
Facilitating barriers: Contextual factors and self-management of type 2 diabetes in urban settings
Banasiak, K., Hux, J. E., Lavergne, C., Luk, J., SOHAL, P. S., & Paty, B. W. (2020) · Health & Place · doi:10.1016/j.healthplace.2019.102267 · Cited by 10
Aplicaciones móviles para mejorar la adherencia a la medicación: revisión y análisis de calidad
de León, B. G., Salas, B. L., del Pino-Sedeño, T., Rodríguez-Álvarez, C., Bejarano-Quisoboni, D., & Trujillo-Martín, M. (2021) · Atención Primaria · doi:10.1016/j.aprim.2021.102095 · Cited by 8
“Sergio Licea 4,5 (847) 4,5 (554) 2,87 (2-4) 1,1 (1-1) 1,8 (1-2)”
Medication adherence in migraine patients (data of an online survey)
Александровна, К. Н., Kiryanova, E. A., & Tabeeva, G. R. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-4-81-87 · Cited by 10
Lindgren, P., Eriksson, J., Buxton, M. J., Kahan, T., Poulter, N. R., Dahlöf, B., Sever, P., Wedel, H., Jönsson, B., & on behalf of the ASCOT trial investigators (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02445.x · Cited by 10
Fukuda, H., Imanaka, Y., Kobuse, H., Hayashida, K., & Murakami, G. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00987.x · Cited by 10
DART Trial team, Kiwuwa-Muyingo, S., Oja, H., Walker, A. S., Ilmonen, P., Levin, J. B., Mambule, I., Reid, A., Mugyenyi, P. N., & Todd, J. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-395 · Cited by 10
“For example, a meta analysis of adherence to drug/placebo showed reduced mortality associated with good adherence to both active drug regimens and to placebo [26].”
MethodKleiner, S. A., Vogt, W. B., Gladowski, P., DEVRIES, A. R., Levin, G., Antonucci, C., & Fong, J. (2009) · American Journal of Medical Quality · doi:10.1177/1062860609345003 · Cited by 10
Kotseva, K. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0415-9 · Cited by 10
Bradbury, K. J., Al‐Abbadey, M., Carnes, D., Dimitrov, B. D., Eardley, S., Fawkes, C. A., Foster, J., Greville-Harris, M., Harvey, J. M., Leach, J., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012209 · Cited by 10
Pan, Y., Yeh, L., Chen, Y., & Chan, H. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.08.007 · Cited by 11
A dual-process view on medication adherence: The role of affect
Kleppe, M., Lacroix, J. P. W., Ham, J. R. C., & Midden, C. (2017) · Journal of Health Psychology · doi:10.1177/1359105317690599 · Cited by 10
Patient adherence to multi-component continuing care discharge plans
Proctor, S. L., Wainwright, J. L., & Herschman, P. L. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.003 · Cited by 8
“Extensive evidence, primarily from the diabetes, hypertension, and asthma treatment literature, supports a link between patient adherence and positive treatment outcomes (for reviews see DiMatteo et al., 2002; Simpson et al., 2006).”
BackgroundIs patient satisfaction the key to promote compliance in health care sector?
Krot, K., & Rudawska, I. (2019) · Economics & Sociology · doi:10.14254/2071-789x.2019/12-3/19 · Cited by 13
Brown, T. J., Twigg, M. J., Taylor, N. J., Easthall, C., Hartt, J., Budd, T., Li, Z., Dima, A. L., & Bhattacharya, D. (2017) · UEA Digital Repository (University of East Anglia) · Cited by 10
Therapeutic adherence to bisphosphonates
Payer, J., Killinger, Z., Šulková, I., & Celec, P. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.02.003 · Cited by 10
Weinman, J. A., O’Carroll, R. E., & Petrie, K. J. (2011) · Wiley eBooks · doi:10.1002/9781444395150.ch3 · Cited by 10
Fosser, S. M., Nadar, M., Habib, B., Weir, D. L., Chan, F. K. I., Halabieh, R. E., Vachon, J., Thakur, M., Tran, T., Bustillo, M., et al. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab037 · Cited by 9
Feasibility Trial of a Comprehensive, Highly Patient-Centered COPD Self-Management Support Program.
Federman, A., O'Conor, R., Nnemnbeng, J. F., Ankam, J., McDermott, D., Lindenauer, P., Wolf, M. S., & Wisnivesky, J. (2023) · Chronic obstructive pulmonary diseases · doi:10.15326/jcopdf.2023.0419 · Cited by 11
Tarekegn, G. Y., Dagnew, F. N., Moges, T. A., Asmare, Z. A., Tsega, S. S., Damtie, D. G., Anberbr, S. S., Semman, M. F., & Bitew, B. E. (2025) · Scientific Reports · doi:10.1038/s41598-025-03748-4 · Cited by 11
“The implications of poor medication adherence can lead to increased disease exacerbations, hospitalizations, and higher mortality rates 36,37 .”
Atrial fibrillation and the 'other drug problem': reducing non-adherence with technology
Nerini, E., Grip, L. T., Camm, A. J., & Giugliano, R. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht174 · Cited by 9
Laubscher, T. A., Evans, C. D., Blackburn, D., Taylor, J., & McKay, S. (2009) · Canadian Family Physician · Cited by 9
Impact of provider mailings on medication adherence by Medicare Part D members
Borah, B. J., Qiu, Y., Shah, N. D., & Gleason, P. P. (2016) · Healthcare · doi:10.1016/j.hjdsi.2016.02.004 · Cited by 9
“Conversely, high adherence rates have been associated with lower health care costs and improved outcomes.(6,9,10) For patients with chronic conditions, including diabetes mellitus, hypertension, and hypercholesterolemia, increased medication adherence has been shown to be associated with fewer hospitalizations and low…”
BackgroundReach, G., Chenuc, G., Maigret, P., Elias-Billon, I., Martinez, L., & Flipo, R. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s227329 · Cited by 9
“This interpretation clarifies also the enigmatic fact that, in randomised clinical trials, patients allocated to placebo consistently exhibit a higher survival rate when they are adherent,(46,47) leading to explanations using the “healthy adherer” concept for this fascinating observation.(46) The data reported herein…”
BackgroundFranke, G. H., Nentzl, J., Jagla-Franke, M., & Prell, T. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s311946 · Cited by 9
Clinical impact of guideline-based practice and patients’ adherence in uncontrolled hypertension
Sohn, I. S., Kim, C.-J., Yoo, B., Kim, B. J., Choi, J. W., Kim, D., Lee, S., Song, W., Jeon, D. W., Jun, T. Y., et al. (2021) · Clinical Hypertension · doi:10.1186/s40885-021-00183-1 · Cited by 9
Determination of Factors Affecting Time in Therapeutic Range in Patients on Warfarin Therapy
Türen, S., & Türen, S. (2022) · Biological Research For Nursing · doi:10.1177/10998004221127977 · Cited by 9
“Poor medication adherence is a major impediment to achieving optimum outcomes in chronic illness (Simpson et al., 2006).”
BackgroundPhysician Perspectives on Implementation of Real-Time Benefit Tools: A Qualitative Study
Everson, J., Whitmore, C. C., Mattingly, T. J., Sinaiko, A. D., & Dusetzina, S. B. (2022) · Applied Clinical Informatics · doi:10.1055/a-1947-2674 · Cited by 9
Lukina, Y. V., Кутишенко, Н. П., Martsevich, S. Y., & Drapkina, O. M. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3603 · Cited by 9
Márk, L., Paragh, G., Karádi, I., Reiber, I., Pados, G., & Kiss, Z. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25549 · Cited by 9
Der Einschluss von Intensivpatienten in klinische Studien
Weimann, A., Kern, B.-R., Löffler, M., Sablotzki, A., Thiele, F., & Brunkhorst, F. M. (2012) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-012-0153-7 · Cited by 9
Mandpe, A. S. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000369 · Cited by 9
E-counseling as an emerging preventive strategy for hypertension
Nolan, R. P., Liu, S., & Payne, A. Y. M. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000080 · Cited by 10
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Kato, D., Tabuchi, H., & Uno, S. (2018) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12237 · Cited by 9
“It is vitally important to explore why patients with OAB tend to discontinue medication because good adherence to drug therapy is known to be associated with positive health outcomes.(37) The most common reason for discontinuing from the present study was unchanged or aggravated symptoms.”
BackgroundQuaschning, K., Koerner, M., & Wirtz, M. A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07987-3 · Cited by 8
Galindo-Ocaña, J., Ortiz-Camúñez, M.-Á., Gil-Navarro, M. V., Porras, E. G., Bernabeu‐Wittel, M., & Santos‐Ramos, B. (2010) · Revista Clínica Española · doi:10.1016/j.rce.2009.11.015 · Cited by 9
Hedna, K., Hägg, S., Sundell, K. A., Petzold, M., & Hakkarainen, K. M. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3528 · Cited by 9
Hashem, M. G., Kevin, C., Fishman, D., Nichols, L., & Khalid, M. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r369 · Cited by 9
Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
Branham, A. R., Moose, J. S., & Ferreri, S. P. (2010) · INNOVATIONS in pharmacy · doi:10.24926/iip.v1i1.195 · Cited by 9
Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy
Fitzgerald, B. P., Conn, K. M., Smith, J., Walker, A., Parkhill, A. L., Hilbert, J. E., Luebbe, E. A., & Moxley, R. T. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8300-3 · Cited by 9
“With the use of any medication, there exists a potential for poor adherence that ultimately results in poorer health outcomes [39, 40].”
BackgroundStatin Adherence and Risk of Accidents: A Cautionary Tale
Gersh, B. J. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(09)79739-4 · Cited by 9
Chakraborty, S. (2012) · Journal of Risk Research · doi:10.1080/13669877.2012.727097 · Cited by 9
“These trials ultimately demonstrated that adherence to treatment regimes yielded better outcomes (Osterberg and Blaschke 2005; Simpson et al. 2006).”
Background[Evidence about the power of intention].
Bonilla, E. (2008) · PubMed · Cited by 9
Improving adherence to prescribed drugs
Neto, A. C. D. A., Aslani, P., & Chen, T. F. (2009) · BMJ · doi:10.1136/bmj.b3282 · Cited by 9
“Non-adherence to prescribed medicines can cause treatment failure, mortality, and increase healthcare costs.”
BackgroundSchwartz, S. W., Cimino, C. R., & Anderson, W. M. (2012) · SLEEP · doi:10.5665/sleep.2218 · Cited by 9
“CPAP or placeboeffect? SLEEP 2012;35(12):1585-1586.”
Donovan, L. M., & Patel, S. R. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1413le · Cited by 9
Springer, F., Esser, P., Friedrich, M., Ernst, J., Platzbecker, U., Vučinić, V., & Mehnert, A. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1278485 · Cited by 9
Primary Care Records of Chronic-Disease Patient Adherence to Treatment
Mesquida, M. M., la Fuente, J. A. D., Lorca, A. M. A., Pillasagua, I. A., Blanco, E. B., Vidal, S. G., Reyes, S. P., Iparraguirre, P. G., Gombau, G. S., & Torán‐Monserrat, P. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073710 · Cited by 8
“By way of example, the results of a meta-analysis [5] of 21 studies (46,847 participants) showed that good adherence was associated with lower mortality as compared to poor adherence (odds ratio 0.”
ResultAdherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document
Casellas, F., González‐Lama, Y., Vicens, D. G., García‐López, S., Muñoz, F., Sánchez, L. M., Camacho, L., Cábez, A., Fortes, M. D. P., Gómez, S., et al. (2021) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2021.8130/2021 · Cited by 8
Drug Adherence in Hypertension
Burnier, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_43 · Cited by 8
Bhattacharya, D., Brown, T. J., Clark, A., Dima, A. L., Easthall, C., Taylor, N. J., & Li, Z. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s427207 · Cited by 9
Patel, S. R., Sawyer, A. M., & Gottlieb, D. J. (2024) · SLEEP · doi:10.1093/sleep/zsae063 · Cited by 8
Reach, G., Guedj-Meynier, D., Darné, B. M., & Herpin, D. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.04.012 · Cited by 9
Greer, A. E., Milner, K. A., Marcello, R. T., & Mazin, K. (2015) · Educational Gerontology · doi:10.1080/03601277.2015.1048147 · Cited by 8
“Such efforts might help CR patients better adhere to their medication regimens, which could ultimately result in decreased morbidity and mortality and reductions in hospital readmissions and health care costs (Dragomir et al., 2010; Simpson et al., 2006).”
BackgroundVarunok, P., Lawitz, E., Beavers, Matusow, Leong, Lambert, Bernaards, Solsky, Brennan, Wat, et al. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s26566 · Cited by 8
National questionnaire of treatment compliance:testing and application in outpatient practice
Фофанова, Т. В., Ageev, F. T., Smirnova, M. D., Николаевна, С. О., Кузьмина, А. Е., Thostov, A. S., & Нелюбина, А. С. (2014) · Systemic Hypertension · doi:10.26442/sg29010 · Cited by 8
Effect of daily azithromycin therapy and adherence on readmission risk in COPD
Krishnan, J. K., Voelker, H. T., Connett, J. E., Niewoehner, D. E., Albert, R. K., Scanlon, P. D., Criner, G. J., Dransfield, M. T., Han, M. K., & Martínez, F. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.01377-2018 · Cited by 8
Walsh, C. A., Cahir, C., & Bennett, K. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02699-w · Cited by 8
Health information–seeking behaviors and adherence to urgent care discharge instructions
Alberti, T. L., & Crawford, S. L. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000262 · Cited by 8
Work Status Reduction and Cost-Related Nonadherence during Cancer Treatment
Doherty, M. J., Finik, J. M., & Blinder, V. S. (2022) · Health & Social Work · doi:10.1093/hsw/hlac004 · Cited by 8
Tan, C., & Xiong, S. (2022) · Current Drug Delivery · doi:10.2174/1567201820666221122124510 · Cited by 8
Kang, J., Choi, S., Park, D.-J., & Lee, S. (2023) · Rheumatology · doi:10.1093/rheumatology/kead306 · Cited by 9
Aguilar, K. M., Hou, Q., & Miller, R. M. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.8.670 · Cited by 8
“conditions, which may result in worsened outcomes and an increased risk of mortality.(2) Additionally, suboptimal medica-”
BackgroundNon-observance thérapeutique et addiction, deux manifestations de l'impatience
Reach, G. (2010) · Psychotropes · doi:10.3917/psyt.154.0071 · Cited by 10
Risiken und Nebenwirkungen durch Non Compliance
Russmann, S., Curkovic, I., & Huber, M. (2010) · Therapeutische Umschau · doi:10.1024/0040-5930/a000054 · Cited by 8
“Non-Compliance wurde in mehreren Studien mit einer erhöhten Gesamtmortalität assoziiert [9].”
BackgroundInfluentialFoody, J. M., Aslam, F., & Lee, V. (2009) · Patient Preference and Adherence · doi:10.2147/ppa.s4201 · Cited by 8
“Indeed, recent data have shown that fi xed-dose combination therapies improve patient adherence compared with the coadministration of single-agent formulation(13) and that good adherence to drug therapy is associated with positive health outcomes.(14)”
Adherence, Placebo Effects, and Mortality
Wilson, I. B. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1530-7 · Cited by 8
Tas legemidler som foreskrevet?
Hov, I., Bjartnes, M., Slørdal, L., & Spigset, O. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.0225 · Cited by 8
Selection of interventions aimed at improving medication adherence in patients with multimorbidity
González-Bueno, J., Calvo-Cidoncha, E., Nieto‐Martín, M. D., Pérez‐Guerrero, C., Ollero‐Baturone, M., & Santos‐Ramos, B. (2017) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2017-001240 · Cited by 8
Chini, C., Bascialla, L., Giaquinto, A., Magni, E., Gobba, S., Proserpio, I., Suter, M. B., Nigro, O., Tinelli, G., & Pinotti, G. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05569-9 · Cited by 9
Against ‘Placebo.’ The Case for Changing our Language, and for the Meaning Response
Moerman, D. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397928-5.00018-0 · Cited by 8
Cea‐Calvo, L., Carmona, L., & Alén, J. C. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0602-z · Cited by 8
Electronically Monitored Adherence to Short-Term Antibiotic Therapy in Children
Youngster, I., Gelernter, R., Klainer, H., Paz, H., Kozer, E., & Goldman, M. (2022) · PEDIATRICS · doi:10.1542/peds.2022-058281 · Cited by 7
Lampridou, S., Rawasdheh, M., Saghdaoui, L. B., Wells, M., & Davies, A. H. (2024) · JVS-Vascular Insights · doi:10.1016/j.jvsvi.2024.100074 · Cited by 7
Metadata
- Authors
- Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A.
- Affiliations
- University of Alberta (CA)
- Institute of Health Economics (CA)
- Corresponding author
- Simpson, Scot H
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2006-06-21
- Volume
- 333
- Issue
- 7557
- Pages
- 15
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC1488752
- OpenAlex
- W2147982456
- Cited by
- 1,353
- References
- 39
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 57 · 2023: 56 · 2022: 55 · 2021: 83 · 2020: 55 · 2019: 74 · 2018: 90 · 2017: 91 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 77 · 2012: 86
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- medication adherence, pharmacotherapy, mortality, adherence measurement methods
- MeSH terms
- Drug Therapy, Epidemiologic Methods, Humans, Patient Compliance, Prognosis, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review